Nicergoline
From Wikipedia, the free encyclopedia
| Image:Nicergoline.png | |
|
Nicergoline
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | |
| ATC code | C04 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C24H26BrN3O3 |
| Mol. mass | 484.386 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Nicergoline is an ergoloid mesylate derivative used to treat senile dementia. It has also been found to increase mental agility and enhance clarity and perception.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
